MRX-1024, an oral D-met suspension, protects against cisplatin-induced ototoxicity in humans Feb. 20, 2009
Provid and U.S. Department of Health & Human Services jointly divulge new Chk2 and RSK2 inhibitors Feb. 20, 2009
Bradmer presents update on phase III GLASS-ART clinical trial of Neuradiab in glioblastoma Feb. 19, 2009
Novel B-Raf kinase inhibitors under development at Boehringer Ingelheim for the treatment of cancer Feb. 19, 2009
RSS